Entity > Corporation > US > New York City New York > Celgene
About Celgene
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Celgene
| Company Attribute | Value |
| Name | Celgene |
| Url | celgene |
| Wikidata | wikidata |
Celgene
New York City, US
1 May 2024
Celgene
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.bms.com/
... Celgene shareholders · Investor contacts. QUICK LINKS. Annual report 2023 · Dividend history · Stock split history · Investment return calculator · SEC filings.
Rich Sitelinks
People Also Ask
https://en.wikipedia.org › wiki › Celgene
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the ...
https://www.celgene.com › research-development › clin...
Celgene is committed to responsible and transparent sharing of clinical trial data with patients, healthcare practitioners and independent researchers for ...
Video Boxes
https://www.forbes.com › companies › celgene
Celgene Corporation is an integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed.
https://www.jonesday.com › experience › 2019/11 › celg...
The transaction creates a leading focused specialty biopharma company well positioned to address the needs of patients with cancer, inflammatory and immunologic ...
https://www.bloomberg.com › company › CELG:US
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to ...
Places / GMB
Related Searches
Celgene stock
Celgene news
Celgene corporation
Knowledge Panel
Celgene (Pharmaceutical company)
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb.
-
Parent organization : Bristol Myers Squibb
-
CEO : Mark J. Alles (Mar 1, 2016–)
-
Subsidiaries : Celgene Pty, Celgene Srl, Anthrogenesis Corp, MORE
-
Headquarters : Summit, NJ
-
Founder : Sol J. Barer
-
Founded : April 17, 1986
-
Acquisition price : $74 billion cnbc.com